H.R. 3320 would expand the scope of a report the Department of State is required to produce concerning observer status for Taiwan at the World Health Organization (WHO). The department provides annual reports to the Congress on its ongoing plans to endorse and obtain that status for Taiwan. The bill would require the department to report on how it would modify those plans if Taiwan could not participate as an observer at certain annual WHO meetings.
Based on information from the department and the cost of similar reports, CBO estimates that implementing the bill would cost less than $500,000 over the 2018-2022 period; such spending would be subject to the availability of appropriated funds.
Enacting H.R. 3320 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply. CBO estimates that enacting H.R. 3320 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2028.
H.R. 3320 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.